Penetrated market share in cardiac segment India FY 2020, by leading company

Lupin Limited had the highest penetrated share in the cardiac segment in the Indian pharmaceutical market of over 76 percent across India in financial year 2020. Intas Biopharmaceuticals had the second highest penetrated share in Cardiac market in the country that year.

在2020财年，Lupin Limited 在印度药品市场的冠状动脉领域占据了超过76%的最高渗透市场份额。Intas 生物制药公司当年在冠状动脉市场中以次高的渗透率份额排名第二。